Finepoint Capital LP - Q1 2023 holdings

$262 Million is the total value of Finepoint Capital LP's 38 reported holdings in Q1 2023. The portfolio turnover from Q4 2022 to Q1 2023 was 18.2% .

 Value Shares↓ Weighting
TVTX SellTRAVERE THERAPEUTICS INC$19,683,720
+91100.1%
875,221
-14.7%
7.52%
+7.8%
APLS SellAPELLIS PHARMACEUTICALS INC$18,712,192
+107956.8%
283,690
-15.3%
7.15%
+27.6%
ISEE BuyIVERIC BIO INC$17,605,188
+116105.9%
723,600
+2.3%
6.72%
+37.3%
ACAD SellACADIA PHARMACEUTICALS INC$17,245,763
+91951.0%
916,353
-22.1%
6.59%
+8.8%
GLPG BuyGALAPAGOS NVspon adr$17,181,624
+99078.2%
444,659
+13.9%
6.56%
+17.2%
SRPT SellSAREPTA THERAPEUTICS INC$16,919,597
+99228.4%
122,757
-6.6%
6.46%
+17.4%
ASND BuyASCENDIS PHARMA A/Ssponsored adr$16,734,040
+102123.8%
156,072
+16.4%
6.39%
+20.8%
SAGE BuySAGE THERAPEUTICS INC$16,316,775
+111958.1%
388,865
+1.9%
6.23%
+32.4%
FOLD BuyAMICUS THERAPEUTICS INC$16,193,341
+92741.1%
1,460,175
+2.2%
6.18%
+9.7%
PRTA BuyPROTHENA CORP PLC$16,072,652
+82514.5%
331,600
+2.7%
6.14%
-2.4%
SWTX SellSPRINGWORKS THERAPEUTICS INC$15,810,306
+94436.6%
614,231
-4.5%
6.04%
+11.7%
CYTK BuyCYTOKINETICS INC$14,561,376
+78797.8%
413,793
+2.7%
5.56%
-6.8%
CRNX BuyCRINETICS PHARMACEUTICALS IN$13,946,938
+92533.8%
868,427
+5.6%
5.33%
+9.4%
RLAY BuyRELAY THERAPEUTICS INC$13,938,067
+130406.2%
846,270
+18.4%
5.32%
+54.2%
ARVN BuyARVINAS INC$13,449,636
+91412.8%
492,300
+14.6%
5.14%
+8.1%
CERE BuyCEREVEL THERAPEUTICS HLDNG I$13,157,064
+80544.0%
539,445
+4.3%
5.03%
-4.7%
BuySOLID BIOSCIENCES INC$2,317,182
+196939.3%
488,857
+123.7%
0.88%
+132.9%
AACWS  ARES ACQUISITION CORP*w exp 02/02/202$444,141
+188896.2%
504,7060.0%0.17%
+123.7%
 HOME PLATE ACQUISITION CORP*w exp 09/30/202$218,730
+3124614.3%
690,0000.0%0.08%
+4100.0%
BTWNW  BRIDGETOWN HOLDINGS LTD*w exp 09/30/202$134,429
+130413.6%
895,0000.0%0.05%
+54.5%
ROSSWS  ROSS ACQUISITION CORP II*w exp 02/01/202$115,192
+523500.0%
439,6660.0%0.04%
+528.6%
CCVWS  CHURCHILL CAPITAL CORP V*w exp 10/29/202$114,322
+233210.2%
612,0000.0%0.04%
+175.0%
 CONYERS PARK III ACQUISITION CORP*w exp 08/12/202$114,333
+134409.4%
571,6660.0%0.04%
+63.0%
 MARBLEGATE ACQUISITION CORP*w exp 08/31/202$110,177
+379820.7%
735,0000.0%0.04%
+366.7%
NewYS BIOPHARMA CO LTD*w exp 03/15/202$76,293489,999
+100.0%
0.03%
CVIIWS  CHURCHILL CAPITAL CORP VII*w exp 02/29/202$67,130
+248529.6%
548,0000.0%0.03%
+188.9%
 JAWS HURRICANE ACQUISITION CORP*w exp 03/26/202$60,062
+96774.2%
387,2490.0%0.02%
+15.0%
 ZIMMER ENERGY TRANSITION ACQUISITION CORP*w exp 06/16/202$60,118
+88308.8%
358,2700.0%0.02%
+4.5%
 AFTERNEXT HEALTHTECH ACQUISITION CORP*w exp 99/99/999$61,087
+218067.9%
366,6660.0%0.02%
+155.6%
CCVIWS  CHURCHILL CAPITAL CORP VI*w exp 02/17/202$59,400
+185525.0%
540,0000.0%0.02%
+130.0%
 COMPASS DIGITAL ACQUISITION CORP*w exp 09/29/202$59,834
+161613.5%
459,9060.0%0.02%
+91.7%
 SWIFTMERGE ACQUISITION CORP*w exp 12/13/202$59,878
+166227.8%
490,0000.0%0.02%
+91.7%
 CORSAIR PARTNERING CORP*w exp 07/06/202$53,580
+48609.1%
334,6660.0%0.02%
-44.4%
SNRHW  SENIOR CONNECT ACQUISITION COR*w exp 12/31/202$51,308
+84011.5%
1,014,0000.0%0.02%0.0%
 CONCORD ACQUISITION CORP II*w exp 99/99/999$28,583
+60714.9%
408,3330.0%0.01%
-26.7%
 FIRST LIGHT ACQUISITION GROUP INC*w exp 03/14/202$26,863
+81303.0%
655,2000.0%0.01%
-9.1%
 BILANDER ACQUISITION CORP*w exp 05/19/202$23,887
+72284.8%
183,7490.0%0.01%
-18.2%
 SKYDECK ACQUISITION CORP*w exp 05/13/202$18,088
+258300.0%
361,7560.0%0.01%
+250.0%
ExitCATALYST PARTNERS ACQUISITION*w exp 05/12/202$0-336,666
-100.0%
0.00%
LVRAW ExitLEVERE HOLDINGS CORP*w exp 03/09/202$0-274,999
-100.0%
-0.00%
ExitBERENSON ACQUISITION CORP I*w exp 08/01/202$0-862,499
-100.0%
-0.01%
ExitSUMMIT HEALTHCARE ACQUISITION CORP*w exp 06/03/202$0-489,999
-100.0%
-0.04%
ExitDISH NETWORK CORPORATIONnote 12/1$0-15,000,000
-100.0%
-3.12%
IOVA ExitIOVANCE BIOTHERAPEUTICS INC$0-1,545,589
-100.0%
-3.19%
ExitALGOMA STL GROUP INC$0-3,219,441
-100.0%
-6.60%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2023-05-12
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
YPF SOCIEDAD ANONIMA17Q4 201832.7%
IRSA INVERSIONES Y REP S A15Q2 201810.1%
CHENIERE ENERGY INC14Q1 201829.9%
ALLY FINL INC13Q4 201742.0%
CRESUD S A C I F Y A13Q4 20174.0%
BRIDGETOWN HOLDINGS LTD9Q3 20230.2%
ARES ACQUISITION CORP9Q3 20230.2%
CHURCHILL CAPITAL CORP V9Q3 20230.2%
CHURCHILL CAPITAL CORP VII9Q3 20230.1%
CHURCHILL CAPITAL CORP VI9Q3 20230.1%

View Finepoint Capital LP's complete holdings history.

Latest filings
TypeFiled
13F-HR2024-02-13
13F-HR2023-11-13
13F-HR2023-08-11
13F-HR2023-05-12
13F-HR2023-02-13
13F-HR2022-11-10
13F-HR2022-08-12
13F-HR2022-05-13
13F-HR2022-02-11
13F-HR2021-11-12

View Finepoint Capital LP's complete filings history.

Compare quarters

Export Finepoint Capital LP's holdings